Retatrutide, an innovative medication, showed significant weight loss, knee osteoarthritis pain, and sleep apnea in clinical trials. The drug caused considerable decrease in body mass and reduced A1C levels in people with excess weight and metabolic syndrome. The results were published in HCPLive, showing the drug's potential in addressing diverse health concerns.